ArticleHeliyon2023
Examining obesity kuznets curve in the United States from the perspective of globalization and biocapacity.
Article in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Wealth and weight revisited: A Bayesian model averaging approach to the Obesity Kuznets Curve.The European journal of health economics : HEPAC : health economics in prevention and care · 2026Article
- The influence of combined training sequence on adiposity indices in overweight women.Clinics (Sao Paulo, Brazil) · 2026Article
- Bridging the gap in obesity research: A consensus statement from the European Society for Clinical Investigation.European journal of clinical investigation · 2025Review
- Does income have a non-linear impact on residents' BMI? Re-examining the obesity Kuznets curve.BMC public health · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Given the recent rise in the adult obesity prevalence in the United States, the central and state-level governments and health agencies in the country are considering appropriate measures. Further motivation for this investigation stems from the United Nations Sustainable Development Goals (UNSDG-3, 8, and 13), that highlights the need for sustainable health for all, sustainable decent economic growth amidst environmental sustainability. Driven by this motivation, this study investigates the validity of Obesity Kuznets curve (OKC) in the United States over the experimental period of 1975-2016. In addition, this study illustrates the (mediating) role of globalisation and biocapacity in controlling the prevalence of obesity in the United States. While the study established the validity of obesity Kuznets curve, especially in the short run, it found an inverted U-shaped relationship between globalisation and obesity for the United States. This interprets that a significant reduction in wealth-related health issues is achievable with increased (socioeconomic and political) globalisation policy amidst improved (socioeconomic) welfare of the Americans. Moreover, biocapacity showed a desirable impact on obesity since the short- and long-run relationship with a respective elasticity of 0.02 and 1.86 is negative and statistically significant. In general, this study puts forward policy from the perspective of socioeconomic and political globalisation and domestic welfare measures across the country.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.